These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Recent knowledge in the pathophysiology, pathogenesis and hemodynamics of arterial hypertension as a base for scientifically founded diagnosis and therapy]. Wedler B Z Arztl Fortbild (Jena); 1984; 78(24):1011-8. PubMed ID: 6528646 [No Abstract] [Full Text] [Related]
4. A vaccine for hypertension. Ménard J J Hypertens; 2007 Jan; 25(1):41-6. PubMed ID: 17143170 [No Abstract] [Full Text] [Related]
5. Volume and vasoconstriction in experimental renovascular hypertension. Freeman RH; Davis JO; Seymour AA Fed Proc; 1982 Jun; 41(8):2409-14. PubMed ID: 7044827 [TBL] [Abstract][Full Text] [Related]
6. Structural regression of the vasculature during antihypertensive treatment. Jern S; Sivertsson R J Clin Hypertens; 1987 Sep; 3(3):355-9. PubMed ID: 3668595 [No Abstract] [Full Text] [Related]
7. Regional blood flows and cardiac hemodynamics in renovascular and mineralocorticoid hypertensive rats. Charocopos F; Hatzinikolaou P; Gavras I; Gavras H J Physiol (Paris); 1984; 79(3):162-5. PubMed ID: 6381695 [TBL] [Abstract][Full Text] [Related]
8. The adrenal cortex and hypertension. Mulrow PJ Prim Care; 1983 Mar; 10(1):87-98. PubMed ID: 6553941 [No Abstract] [Full Text] [Related]
9. Success in management of renovascular hypertension: why so? Vaughan ED Am J Nephrol; 1981; 1(3-4):133-7. PubMed ID: 6217748 [No Abstract] [Full Text] [Related]
10. Pediatric hypertension. Ingelfinger JR Major Probl Clin Pediatr; 1982; 24():1-297. PubMed ID: 7047912 [No Abstract] [Full Text] [Related]
11. [Renal sequelae of sympathetic hyperactivity]. Watschinger B; Habicht A Wien Med Wochenschr; 2004; 154 Spec No 1(1):7-9. PubMed ID: 15346546 [No Abstract] [Full Text] [Related]
12. Antihypertensive properties of a new long-acting angiotensin converting enzyme inhibitor in renin-dependent and independent hypertensive models. Nagata S; Takeyama K; Fukuya F; Nagai R; Hosoki K; Nishimura K; Deguchi T; Karasawa T Arzneimittelforschung; 1995 Aug; 45(8):853-8. PubMed ID: 7575746 [TBL] [Abstract][Full Text] [Related]
13. [A 100-year perspective on renal function and hypertension. Anti-renin therapy has made hypertensive renal failure a rarity]. Bergström G; Herlitz H; Himmelmann A; Ljungman S; Aurell M Lakartidningen; 1999 Nov; 96(47):5209-14. PubMed ID: 10608112 [TBL] [Abstract][Full Text] [Related]
14. [Comparative evaluation of the effect of bradykinin and angiotensin II on hemodynamics in normotensive rats, spontaneously hypertensive rats and rats with renovascular hypertension]. Ismailov ShI Biull Eksp Biol Med; 1982 Mar; 93(3):57-61. PubMed ID: 7093485 [TBL] [Abstract][Full Text] [Related]
15. The Franz Gross Memorial Lecture. The renin-aldosterone connection: past, present and future. Robertson JI J Hypertens Suppl; 1984 Dec; 2(3):S1-14. PubMed ID: 6400362 [No Abstract] [Full Text] [Related]
16. Renal and endocrine hypertension. A review. Chan JC Int J Pediatr Nephrol; 1983 Sep; 4(3):187-96. PubMed ID: 6358076 [TBL] [Abstract][Full Text] [Related]
18. The role of salt in hypertension: the complexity seems to become clearer. Frohlich ED Nat Clin Pract Cardiovasc Med; 2008 Jan; 5(1):2-3. PubMed ID: 18073713 [No Abstract] [Full Text] [Related]
19. Vascular remodeling in hypertension: mechanisms and treatment. Schiffrin EL Hypertension; 2012 Feb; 59(2):367-74. PubMed ID: 22203749 [No Abstract] [Full Text] [Related]
20. John Laragh and the renin thesis: creating a paradigm. Weber MA Am J Hypertens; 2014 Aug; 27(8):1008-9. PubMed ID: 25103931 [No Abstract] [Full Text] [Related] [Next] [New Search]